My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
WORK PLANS
Environmental Health - Public
>
EHD Program Facility Records by Street Name
>
F
>
FREMONT
>
2050
>
3500 - Local Oversight Program
>
PR0543791
>
WORK PLANS
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
10/1/2018 3:20:21 AM
Creation date
9/28/2018 4:04:30 PM
Metadata
Fields
Template:
EHD - Public
ProgramCode
3500 - Local Oversight Program
File Section
WORK PLANS
RECORD_ID
PR0543791
PE
3526
FACILITY_ID
FA0003592
FACILITY_NAME
Aries Tek, LLC
STREET_NUMBER
2050
Direction
E
STREET_NAME
FREMONT
STREET_TYPE
St
City
Stockton
Zip
95205
CURRENT_STATUS
02
SITE_LOCATION
2050 E Fremont St
P_LOCATION
01
P_DISTRICT
001
QC Status
Approved
Scanner
TMorelli
Tags
EHD - Public
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
71
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
MONITORING AND REPORTING PROGRAM ORDER NO , R5-2008-0149-XXX 4 <br /> APACHE PLASTICS (Former) <br /> SAN JOAQUIN COUNTY <br /> Table 1A : Samplings Frequency (Prior to Full-Scale Implementation) <br /> Well ID Frequency Constituent Suite(s)3Monitoring Objective <br /> MW-9, MW-13, M W- <br /> 23, MW-24, EW-1 , Other Suites A and B Treatment Zones <br /> VEW-1 and VEW-2 <br /> MW-2, MW-8 and Other Suites A and B Transition Zones <br /> MW-21 and MW-22 <br /> MW-5 and MW-20 Other Suites A and B Background Zone' <br /> MW-6, MW- 10 and Other Suites A and B Compliance Zone <br /> MW-11 <br /> Well IDs shown on attached Figure 2 <br /> 2 i.e., weekly, monthly, quarterly, annually, other <br /> 3 Constituent suite components listed in Table 2 below <br /> ° Well used to monitor compliance and for the presence of breakdown/byproducts of the treatment migrating beyond the expected treatment <br /> area <br /> s Wells used to evaluate in-situ bioremediation progress inside the treatment zone, to gauge effectiveness of ISCO injection in reducing the <br /> dissolved petroleum hydrocarbon concentrations, and to monitor potential changes in groundwater geochemistry that could be attributed <br /> to the injection of oxidizing agents <br /> ° <br /> Well used to evaluate migration of pollutants within the treatment zone. The transition well may or may not be within the zone of influence. <br /> ' <br /> Well used to monitor the background natural changes in groundwater geochemistry in areas unaffectedby oxidant injection. <br /> ° To be sampled prior to startup (baseline). <br /> ' All sampling conducted following a 3-well volume purge. <br /> Table 1 B : Samplings, Frequency (During Periods of No Remediation/Progress or Post- <br /> Remediation ) <br /> Well ID Frequency Constituent Suite(s) Monitoring Objective <br /> MW-9, MW-13, MW-23, <br /> MW-24 , EW-1 , VEW-1 Quarterly 4,6 Suites A and B Evaluation of Treatment <br /> and VEW-2 <br /> MW-2, MW-8, MW-21 Quarterly Suites A and B Evaluation of Treatment and <br /> and MW-22 Plume Movement <br /> MW-5 and MW-20 Quarterly 4,6 Suites A and B Evaluation of Background <br /> Conditions <br /> MW-6, MW-10 and Quarterly Suites and B as Evaluation of Adverse <br /> MW-11 Migration of Contaminants <br /> ' Well IDs shown on attached Figure 4 <br /> i.e. , weekly, monthly, quarterly, annually, other <br /> 3 Constituent suite components listed in Table 2 <br /> ° Wells to be monitored for depth to water, presence of free product, and purge sampled on a quarterly basis for two quarters following the <br /> initial span of the four- td-weekly injections to determine if breakdown/byproducts of treatment developed. If results do not indicate any <br /> development of breakdown/byproducts from treatment, no additional samples will be collected. <br /> All sampling conducted following a 3-well volume purge. <br /> ° Should adverse water quality conditions occur due to the injection of oxidants, injections shall cease and those wells showing impacts will <br /> be monitored and reported monthly for the injection permit constituents of concern in Suite B as idenfified during the full-scale, until baseline <br /> is reached, per Finding 3, page 2, paragraph 2 above <br /> Table 2 : Analytical Methods <br /> Constituent Method' Maximum Practical z Frequency <br /> Quantitation Limit (pg/L) <br /> Suite A <br /> TPH-g GC/MS 50 As indicated in <br />
The URL can be used to link to this page
Your browser does not support the video tag.